XML 51 R37.htm IDEA: XBRL DOCUMENT v3.20.4

Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following table summarizes the changes in the carrying amount of goodwill:

(in millions)						Amount
Balance at December 31, 2019						$	4,117
Goodwill resulting from the acquisition of Immunomedics						3,991
Balance at December 31, 2020						$	8,108

Indefinite-Lived Intangible Assets

The following table summarizes our Intangible assets, net:

						December 31, 2020																								December 31, 2019
(in millions)						Gross  Carrying Amount						Accumulated Amortization						Foreign Currency Translation Adjustment						Net Carrying Amount						Gross  Carrying Amount						Accumulated Amortization						Foreign Currency Translation Adjustment						Net Carrying Amount
Finite-lived assets
Intangible asset - sofosbuvir						$	10,720					$	(4,952)					$	—					$	5,768					$	10,720					$	(4,253)					$	—					$	6,467
Intangible asset - axicabtagene ciloleucel (DLBCL)						6,200						(1,105)						—						5,095						6,200						(761)						—						5,439
Intangible asset - Trodelvy for mTNBC						4,600						(63)						—						4,537						—						—						—						—
Other						1,377						(540)						(1)						836						1,098						(454)						(6)						638
Total finite-lived assets						22,897						(6,660)						(1)						16,236						18,018						(5,468)						(6)						12,544
Indefinite-lived assets - IPR&D(1)						16,890						—						—						16,890						1,247						—						(5)						1,242
Total intangible assets						$	39,787					$	(6,660)					$	(1)					$	33,126					$	19,265					$	(5,468)					$	(11)					$	13,786

________________________________

(1)     Includes indefinite-lived assets - IPR&D recognized as part of the Immunomedics acquisition in October 2020. See Note 6. Acquisitions for additional information.

Finite-Lived Intangible Assets

The following table summarizes our Intangible assets, net:

						December 31, 2020																								December 31, 2019
(in millions)						Gross  Carrying Amount						Accumulated Amortization						Foreign Currency Translation Adjustment						Net Carrying Amount						Gross  Carrying Amount						Accumulated Amortization						Foreign Currency Translation Adjustment						Net Carrying Amount
Finite-lived assets
Intangible asset - sofosbuvir						$	10,720					$	(4,952)					$	—					$	5,768					$	10,720					$	(4,253)					$	—					$	6,467
Intangible asset - axicabtagene ciloleucel (DLBCL)						6,200						(1,105)						—						5,095						6,200						(761)						—						5,439
Intangible asset - Trodelvy for mTNBC						4,600						(63)						—						4,537						—						—						—						—
Other						1,377						(540)						(1)						836						1,098						(454)						(6)						638
Total finite-lived assets						22,897						(6,660)						(1)						16,236						18,018						(5,468)						(6)						12,544
Indefinite-lived assets - IPR&D(1)						16,890						—						—						16,890						1,247						—						(5)						1,242
Total intangible assets						$	39,787					$	(6,660)					$	(1)					$	33,126					$	19,265					$	(5,468)					$	(11)					$	13,786

________________________________

(1)     Includes indefinite-lived assets - IPR&D recognized as part of the Immunomedics acquisition in October 2020. See Note 6. Acquisitions for additional information.

Estimated Future Amortization Expense of Finite-Lived Intangible Assets

(in millions)						Amount
2021						$	1,527
2022						1,527
2023						1,527
2024						1,527
2025						1,521
Thereafter						8,607
Total						$	16,236

X

- References

No definition available.

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267

+ Details

Name:	us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b),(d)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration